Xcovery Holdings, Inc., (Xcovery) an evidence-based, innovation-driven pharmaceutical company, today announced an agreement with EVERSANA®, a leading provider of commercialization services to the ...
Impact of Baseline BCR-ABL Mutations on Response to Nilotinib in Patients With Chronic Myeloid Leukemia in Chronic Phase We retrospectively analyzed 38 patients with ALK-positive DLBCL treated with ...
A collaboration between scientists from St. Jude Children's Research Hospital and Dana-Farber Cancer Institute uncovered four proteins that govern the identity of anaplastic large cell lymphoma (ALCL) ...
Implant rupture must be ruled out in the presence of a large fluid effusion surrounding the implant. Effusions that develop within 1 year of surgery may indicate a postsurgical hematoma or effusion, ...
Lymphomas belong to the group of malignant diseases of the immune system and mainly affect the organs of the lymphatic system. Anaplastic large cell lymphoma (ALCL) belongs to the subgroup of ...
An anaplastic lymphoma kinase (ALK)-targeted agent induced high response rates for adults with ALK-positive anaplastic large cell lymphoma (ALCL) who had failed on brentuximab vedotin (Adcetris), a ...
Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a rare T‐cell lymphoma that emerges in the periprosthetic capsule surrounding breast implants, particularly those with a textured ...
Swissmedic said Monday that based on the currently available information, the association Swiss Plastic Surgery recommends using smooth implants rather than textured implants where permitted by the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results